Quantcast Industry Forum
CTSNet is sponsored in part by an educational grant from
CTSNet Sponsor Logos
ABOUT US  |  CONTACT US  | 

Industry Forum

The Ross Summit II, 2009 - "Toward A Pulmonary Autograft Renaissance"

The Ross Summit II, 2009 - "Toward A Pulmonary Autograft Renaissance" will be held 25-26 September 2009 at the Elkins Learning Center, CryoLife, Atlanta, Georgia USA.
For information, contact: Scott Rollins
Phone: 1 678-290-4302
Email: rollins.scott@cryolife.com
Additional information  

- Industry Forum Headlines -

100,000 Cardioblate Cases Worldwide
10-May-2009

100000 Cardioblate Cases WorldwideThis year, Medtronic celebrates 100,000 surgical ablation cases worldwide. Since beginning development in 1996, Medtronic has engineered innovative solutions for cardiac surgical ablation.

There from the beginning, you can continue to count on Medtronic as your trusted partner into the future.

To learn more, visit www.ConductionBlock.com

Cardioblate and Gemini are registered trademarks of Medtronic, Inc.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. See Instructions for Use for a complete list of warnings, precautions and contraindications.

- Let Them Know What You Think! -

Email:

This field is optional. Leave it empty
if you wish to remain anonymous

Company:

Comments:

Send
INDUSTRY SURVEY

CTSNet hosts brief surveys on behalf of corporate sponsors to understand current practice trends. Have you taken the most recent survey:

Cardiovascular Practice Trends.

FEATURED PRODUCTS

CTSNet, Inc. does not
endorse any product, service,
or company listed as a Featured Product.
[ Full Disclaimer ]

RELATED SECTIONS
TOOLKIT
CTSNET SPONSORSHIP

Does your company support CTSNet, the largest online community of cardiothoracic surgeons in the world? Become a CTSNet Sponsor or Industry Forum Participant.

Copyright © 1998 - 2009 by CTSNet. CTSNet is a registered trademark of the Cardiothoracic Surgery Network.
All rights reserved. See the Expanded Proprietary Legend and Disclaimer.